Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
638
datasets available to search
ShareScore release 0.9.0
Dataset results
638 results for “erlotinib”
APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT00652340. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
ClinicalTrials.gov study NCT00473083. IPD Sharing: Not stated. Countries: 1. Publications: 21.
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
ClinicalTrials.gov study NCT00365391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TARCEVA (Erlotinib) in Combination With Chemoradiation in Patients With Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00563784. IPD Sharing: Not stated. Countries: 1. Publications: 1.
AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02296125. IPD Sharing: YES. Countries: 30. Publications: 13.
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
ClinicalTrials.gov study NCT00410826. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Erlotinib and Sorafenib in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
ClinicalTrials.gov study NCT00445588. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01866410. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
ClinicalTrials.gov study NCT00442507. IPD Sharing: Not stated. Countries: 1. Publications: 20.
Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
ClinicalTrials.gov study NCT01180959. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of Erlotinib + Radiotherapy for Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00369512. IPD Sharing: Not stated. Countries: 1. Publications: 1.
BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC
ClinicalTrials.gov study NCT00410059. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01104155. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01026844. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00445848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00367601. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma
ClinicalTrials.gov study NCT00059787. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00949910. IPD Sharing: Not stated. Countries: 51. Publications: 2.
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
ClinicalTrials.gov study NCT00257608. IPD Sharing: Not stated. Countries: 17. Publications: 1.
BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
ClinicalTrials.gov study NCT00656136. IPD Sharing: Not stated. Countries: 15. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.